000170223 001__ 170223
000170223 005__ 20260407115449.0
000170223 0247_ $$2doi$$a10.1016/j.medcli.2026.107388
000170223 0248_ $$2sideral$$a148749
000170223 037__ $$aART-2026-148749
000170223 041__ $$aeng
000170223 100__ $$aGros, Mónica
000170223 245__ $$aDietary intake as a tool to support diagnosis of irritable bowel syndrome
000170223 260__ $$c2026
000170223 5060_ $$aAccess copy available to the general public$$fUnrestricted
000170223 5203_ $$aBackground
Dietary habits are closely related to symptom modulation in irritable bowel syndrome (IBS), yet their characterization remains limited. Understanding habitual food intake in IBS patients may contribute to diagnosis and support personalized management.
Objectives
To identify dietary patterns associated with IBS and to develop a diet-based score to aid in clinical stratification and nutritional guidance.
Methods
A case–control study was conducted including 109 participants (53 IBS patients and 56 healthy controls). Dietary intake was assessed using a validated short food frequency questionnaire. Multivariate logistic regression identified food items that best distinguished IBS patients from controls, which were then used to construct a composite dietary score.
Results
IBS patients exhibited distinct dietary patterns, characterized by higher intake of carbohydrates and lower consumption of dairy products, while fruit and vegetable intake were similar between groups. A score based on the intake of rice, bread, yoghurt, minced meat, and distilled beverages showed good discriminatory capacity (sensitivity: 85.7%, specificity: 81.1%).
Conclusions
IBS patients present characteristic dietary profiles that may have diagnostic and therapeutic implications. The proposed dietary score could serve as a complementary tool to support clinical decision-making and guide personalized nutritional counseling. Further research is warranted to validate its applicability in routine clinical practice.
000170223 536__ $$9info:eu-repo/grantAgreement/ES/DGA/ARAINF-0567-2012$$9info:eu-repo/grantAgreement/ES/DGA/A20-23R
000170223 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttps://creativecommons.org/licenses/by/4.0/deed.es
000170223 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000170223 700__ $$0(orcid)0000-0002-0061-7989$$aGros-Bañeres, Belén$$uUniversidad de Zaragoza
000170223 700__ $$0(orcid)0000-0003-4758-3998$$aMesonero, José Emilio$$uUniversidad de Zaragoza
000170223 700__ $$0(orcid)0000-0002-5797-3909$$aLatorre, Eva$$uUniversidad de Zaragoza
000170223 7102_ $$11012$$2410$$aUniversidad de Zaragoza$$bDpto. Farmac.Fisiol.y Med.L.F.$$cÁrea Fisiología
000170223 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000170223 7102_ $$11002$$2050$$aUniversidad de Zaragoza$$bDpto. Bioq.Biolog.Mol. Celular$$cÁrea Biología Celular
000170223 773__ $$g166, 5 (2026), 107388$$pMed. clín.$$tMedicina clinica$$x0025-7753
000170223 8564_ $$s555721$$uhttps://zaguan.unizar.es/record/170223/files/texto_completo.pdf$$yVersión publicada
000170223 8564_ $$s2102237$$uhttps://zaguan.unizar.es/record/170223/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000170223 909CO $$ooai:zaguan.unizar.es:170223$$particulos$$pdriver
000170223 951__ $$a2026-03-26-14:32:02
000170223 980__ $$aARTICLE